BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26548855)

  • 1. Measurements of Hepatic Metastasis on MR Imaging:: Assessment of Interobserver and Intersequence Variability.
    Karademir I; Ward E; Peng Y; Wise L; Buckle C; Kunnavakkam R; Oto A
    Acad Radiol; 2016 Feb; 23(2):132-43. PubMed ID: 26548855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement variability of liver metastases from neuroendocrine tumors on different magnetic resonance imaging sequences.
    Lestra T; Kanagaratnam L; Mulé S; Janvier A; Brixi H; Cadiot G; Dohan A; Hoeffel C
    Diagn Interv Imaging; 2018 Feb; 99(2):73-81. PubMed ID: 29339222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Magnetic Resonance (MR) Biomarkers for Assessment of Response With Response Evaluation Criteria in Solid Tumors: Comparison of the Measurements of Neuroendocrine Tumor Liver Metastases (NETLM) With Various MR Sequences and at Multiple Phases of Contrast Administration.
    Luersen GF; Wei W; Tamm EP; Bhosale PR; Szklaruk J
    J Comput Assist Tomogr; 2016; 40(5):717-22. PubMed ID: 27636124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is diffusion-weighted MRI sufficient for follow-up of neuroendocrine tumour liver metastases?
    Lavelle LP; O'Neill AC; McMahon CJ; Cantwell CP; Heffernan EJ; Malone DE; Daly L; Skehan SJ
    Clin Radiol; 2016 Sep; 71(9):863-8. PubMed ID: 27345612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High sensitivity of diffusion-weighted MR imaging for the detection of liver metastases from neuroendocrine tumors: comparison with T2-weighted and dynamic gadolinium-enhanced MR imaging.
    d'Assignies G; Fina P; Bruno O; Vullierme MP; Tubach F; Paradis V; Sauvanet A; Ruszniewski P; Vilgrain V
    Radiology; 2013 Aug; 268(2):390-9. PubMed ID: 23533288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant hepatic tumors: short-term reproducibility of apparent diffusion coefficients with breath-hold and respiratory-triggered diffusion-weighted MR imaging.
    Kim SY; Lee SS; Byun JH; Park SH; Kim JK; Park B; Kim N; Lee MG
    Radiology; 2010 Jun; 255(3):815-23. PubMed ID: 20501719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence and Observer Variability in Gadoxectic Acid-Enhanced MRI Lesion Measurements in Hepatocellular Carcinoma.
    van Lunenburg JTJ; Tripathi V; Chan VSH; Lee VKH; Lee EY; Vardhanabhuti V; Chiu KWH
    Acad Radiol; 2020 Apr; 27(4):e64-e71. PubMed ID: 31326308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic contrast-enhanced magnetic resonance imaging measurements in renal cell carcinoma: effect of region of interest size and positioning on interobserver and intraobserver variability.
    Braunagel M; Radler E; Ingrisch M; Staehler M; Schmid-Tannwald C; Rist C; Nikolaou K; Reiser MF; Notohamiprodjo M
    Invest Radiol; 2015 Jan; 50(1):57-66. PubMed ID: 25260094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal liver metastases: contrast agent diffusion coefficient for quantification of contrast enhancement heterogeneity at MR imaging.
    Jia G; O'Dell C; Heverhagen JT; Yang X; Liang J; Jacko RV; Sammet S; Pellas T; Cole P; Knopp MV
    Radiology; 2008 Sep; 248(3):901-9. PubMed ID: 18710983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic Resonance Imaging of Neuroendocrine Tumor Hepatic Metastases: Does Hepatobiliary Phase Imaging Improve Lesion Conspicuity and Interobserver Agreement of Lesion Measurements?
    Morse B; Jeong D; Thomas K; Diallo D; Strosberg JR
    Pancreas; 2017 Oct; 46(9):1219-1224. PubMed ID: 28902795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion-weighted magnetic resonance imaging in metastatic gastrointestinal stromal tumor (GIST): a pilot study on the assessment of treatment response in comparison with 18F-FDG PET/CT.
    Schmidt S; Dunet V; Koehli M; Montemurro M; Meuli R; Prior JO
    Acta Radiol; 2013 Oct; 54(8):837-42. PubMed ID: 23761549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion-weighted MRI of metastatic liver lesions: is there a difference between hypervascular and hypovascular metastases?
    Schmid-Tannwald C; Thomas S; Ivancevic MK; Dahi F; Rist C; Sethi I; Oto A
    Acta Radiol; 2014 Jun; 55(5):515-23. PubMed ID: 23986455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of hepatocellular phase imaging after intravenous gadoxetate disodium for assessing hepatic metastases from gastroenteropancreatic neuroendocrine tumors: comparison with other MRI pulse sequences and with extracellular agent.
    Tirumani SH; Jagannathan JP; Braschi-Amirfarzan M; Qin L; Balthazar P; Ramaiya NH; Shinagare AB
    Abdom Radiol (NY); 2018 Sep; 43(9):2329-2339. PubMed ID: 29470627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra- and interobserver variability of linear and volumetric measurements of brain metastases using contrast-enhanced magnetic resonance imaging.
    Bauknecht HC; Romano VC; Rogalla P; Klingebiel R; Wolf C; Bornemann L; Hamm B; Hein PA
    Invest Radiol; 2010 Jan; 45(1):49-56. PubMed ID: 19996757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dynamic MRI of the liver with parallel acquisition technique: characterization of focal liver lesions and analysis of the hepatic vasculature in a single MRI session].
    Heilmaier C; Sutter R; Lutz AM; Seifert B; Willmann JK
    Rofo; 2008 May; 180(5):440-8. PubMed ID: 18438745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI.
    Donati OF; Hany TF; Reiner CS; von Schulthess GK; Marincek B; Seifert B; Weishaupt D
    J Nucl Med; 2010 May; 51(5):692-9. PubMed ID: 20395324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is gadolinium necessary for MRI follow-up evaluation of cystic lesions in the pancreas? Preliminary results.
    Macari M; Lee T; Kim S; Jacobs S; Megibow AJ; Hajdu C; Babb J
    AJR Am J Roentgenol; 2009 Jan; 192(1):159-64. PubMed ID: 19098196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are pancreatic IPMN volumes measured on MRI images more reproducible than diameters? An assessment in a large single-institution cohort.
    Pandey P; Pandey A; Varzaneh FN; Ghasabeh MA; Fouladi D; Khoshpouri P; Shao N; Zarghampour M; Hruban RH; Canto M; O'Broin-Lennon AM; Kamel IR
    Eur Radiol; 2018 Jul; 28(7):2790-2800. PubMed ID: 29404774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR diagnosis of hepatic metastases from neuroendocrine tumors versus hemangiomas: relative merits of dynamic gadolinium chelate-enhanced gradient-recalled echo and unenhanced spin-echo images.
    Soyer P; Gueye C; Somveille E; Laissy JP; Scherrer A
    AJR Am J Roentgenol; 1995 Dec; 165(6):1407-13. PubMed ID: 7484575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there a systematic bias of apparent diffusion coefficient (ADC) measurements of the breast if measured on different workstations? An inter- and intra-reader agreement study.
    Clauser P; Marcon M; Maieron M; Zuiani C; Bazzocchi M; Baltzer PA
    Eur Radiol; 2016 Jul; 26(7):2291-6. PubMed ID: 26443604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.